Biologic Drugs With Mechanism of Action: CD30-directed Antibody Interactions
✉ Email this page to a colleague
Biologic Drugs With Mechanism of Action: CD30-directed Antibody Interactions
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Seattle Genetics, Inc. | ADCETRIS | brentuximab vedotin | For Injection | 125388 | 2011-08-19 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Patent Expiration |